BSBE(SZ:300406) Xin Lang Cai Jing·2026-01-12 03:35Group 1 - The core viewpoint of the news is that Jiukang Bio has shown a positive stock performance recently, with a year-to-date increase of 6.12% and a market capitalization of 8.132 billion yuan [1] - As of January 12, Jiukang Bio's stock price was 13.87 yuan per share, with a trading volume of 61.5571 million yuan and a turnover rate of 1.06% [1] - The company primarily engages in the research, production, and sales of biochemical diagnostics, blood coagulation testing, blood type testing, and tumor pathology testing, with 95.09% of its revenue coming from in vitro diagnostic reagents [1] Group 2 - As of September 30, Jiukang Bio reported a decrease in revenue to 1.012 billion yuan, a year-on-year decline of 18.24%, and a net profit of 272 million yuan, down 27.03% year-on-year [2] - The number of shareholders decreased by 2.48% to 18,100, while the average circulating shares per person increased by 2.54% to 23,502 shares [2] - The company has distributed a total of 1.33 billion yuan in dividends since its A-share listing, with 701 million yuan distributed over the past three years [3]